Advertisement
U.S. markets closed

Brasil Pharma S.A. (BPHA3.SA)

São Paulo - São Paulo Delayed Price. Currency in BRL
0.62000.0000 (0.00%)
At close: 05:05PM BRT
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
Total Revenue
8,466
Cost of Revenue
168
Gross Profit
8,298
Operating Expense
31,892
Operating Income
-23,594
Net Non Operating Interest Income Expense
1,067,770
Pretax Income
1,145,010
Tax Provision
-7,458
Net Income Common Stockholders
1,176,492
Diluted NI Available to Com Stockholders
1,176,492
Basic EPS
10.40
Diluted EPS
10.40
Basic Average Shares
113,081
Diluted Average Shares
113,081
Total Expenses
32,060
Net Income from Continuing & Discontinued Operation
1,176,492
Normalized Income
1,151,499
Interest Income
1,055,447
Interest Expense
6,508
Net Interest Income
1,067,770
EBIT
1,151,518
EBITDA
1,161,351
Reconciled Cost of Revenue
168
Reconciled Depreciation
9,833
Net Income from Continuing Operation Net Minority Interest
1,152,468
Total Unusual Items Excluding Goodwill
1,468
Total Unusual Items
1,468
Normalized EBITDA
1,159,883
Tax Rate for Calcs
0
Tax Effect of Unusual Items
499.12